Skip to main content
. 2018 May 31;20(Suppl F):F1–F74. doi: 10.1093/eurheartj/suy019

Figure 37.

Figure 37

Criteria for the interruption of dual antiplatelet therapy (DAPT) in patients undergoing percutaneous coronary intervention (PCI) and candidates for non-cardiac surgery.

ACS - Acute coronary syndrome.

124-hour site cath lab is recommended if major surgery is undertaken within six months post-PCI.

2Prevention of stent thrombosis during adequate antiplatelet therapy; stenting of the last patent coronary artery; extensive multivessel coronary disease, particularly in diabetic patients; chronic renal failure (creatinine clearance < 60 ml/min); at least 3 implanted stents; at least 3 lesions treated; bifurcation with 2 implanted stents; total length of the stent >60 mm; treatment of chronic total occlusions.

Reproduced with permission from Valgimigli et al.57